Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mouse models of pancreatic cancer
Marta Herreros‐Villanueva
World Journal of Gastroenterology (2012) Vol. 18, Iss. 12, pp. 1286-1286
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells
Alistair Rice, E Cortés, Dariusz Lachowski, et al.
Oncogenesis (2017) Vol. 6, Iss. 7, pp. e352-e352
Open Access | Times Cited: 453
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer
Marcus Ruscetti, John P. Morris, Riccardo Mezzadra, et al.
Cell (2020) Vol. 181, Iss. 2, pp. 424-441.e21
Open Access | Times Cited: 309
Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors
Assaf Zinger, Lilach Koren, Omer Adir, et al.
ACS Nano (2019) Vol. 13, Iss. 10, pp. 11008-11021
Open Access | Times Cited: 266
Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment
Corina Kim-Fuchs, Caroline P. Le, Matthew A. Pimentel, et al.
Brain Behavior and Immunity (2014) Vol. 40, pp. 40-47
Open Access | Times Cited: 230
A High-Fat Diet Activates Oncogenic Kras and COX2 to Induce Development of Pancreatic Ductal Adenocarcinoma in Mice
Bincy Philip, Christina L. Roland, Jarosław Daniluk, et al.
Gastroenterology (2013) Vol. 145, Iss. 6, pp. 1449-1458
Open Access | Times Cited: 228
CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer
Jorge Franco, Agnieszka K. Witkiewicz, Erik S. Knudsen
Oncotarget (2014) Vol. 5, Iss. 15, pp. 6512-6525
Open Access | Times Cited: 204
MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype
Nicole M. Sodir, Roderik M. Kortlever, Valentin J.A. Barthet, et al.
Cancer Discovery (2020) Vol. 10, Iss. 4, pp. 588-607
Open Access | Times Cited: 154
Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer
Nagaraj S. Nagathihalli, Jason Castellanos, Chanjuan Shi, et al.
Gastroenterology (2015) Vol. 149, Iss. 7, pp. 1932-1943.e9
Open Access | Times Cited: 171
Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy
Richard Sleightholm, Beth K. Neilsen, Jing Li, et al.
Pharmacology & Therapeutics (2017) Vol. 179, pp. 158-170
Closed Access | Times Cited: 163
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo
Luigi Leanza, Matteo Romio, Katrin Anne Becker, et al.
Cancer Cell (2017) Vol. 31, Iss. 4, pp. 516-531.e10
Open Access | Times Cited: 153
Patient-derived tumor organoids for prediction of cancer treatment response
Peter W. Nagle, John Th. M. Plukker, Christina T. Muijs, et al.
Seminars in Cancer Biology (2018) Vol. 53, pp. 258-264
Open Access | Times Cited: 149
Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy
María P. Torres, Satyanarayana Rachagani, Joshua J. Souchek, et al.
PLoS ONE (2013) Vol. 8, Iss. 11, pp. e80580-e80580
Open Access | Times Cited: 126
An Immunosuppressive Dendritic Cell Subset Accumulates at Secondary Sites and Promotes Metastasis in Pancreatic Cancer
Justin A. Kenkel, William W. Tseng, Matthew G. Davidson, et al.
Cancer Research (2017) Vol. 77, Iss. 15, pp. 4158-4170
Open Access | Times Cited: 105
Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9
Umashankar K. Ballehaninna, Ronald S. Chamberlain
Tumor Biology (2013) Vol. 34, Iss. 6, pp. 3279-3292
Closed Access | Times Cited: 104
Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy
Jun Zhao, Huamin Wang, Cheng-Hui Hsiao, et al.
Biomaterials (2018) Vol. 159, pp. 215-228
Open Access | Times Cited: 104
Laser-assisted 3D bioprinting of exocrine pancreas spheroid models for cancer initiation study
D. Hakobyan, Chantal Médina, Nathalie Dusserre, et al.
Biofabrication (2020) Vol. 12, Iss. 3, pp. 035001-035001
Closed Access | Times Cited: 104
Interleukin-6: a villain in the drama of pancreatic cancer development and progression
Reinhild Holmer, Freya A. Goumas, Georg H. Waetzig, et al.
Hepatobiliary & pancreatic diseases international (2014) Vol. 13, Iss. 4, pp. 371-380
Closed Access | Times Cited: 103
Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting
Ramesh Pothuraju, Satyanarayana Rachagani, Wade M. Junker, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 103
Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans
Mami Takahashi, Mika Hori, Rikako Ishigamori, et al.
Cancer Science (2018) Vol. 109, Iss. 10, pp. 3013-3023
Open Access | Times Cited: 102
Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility
Erik S. Knudsen, Uthra Balaji, Brian K. Mannakee, et al.
Gut (2017) Vol. 67, Iss. 3, pp. 508-520
Open Access | Times Cited: 99
Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment
Kishore Polireddy, Qi Chen
Journal of Cancer (2016) Vol. 7, Iss. 11, pp. 1497-1514
Open Access | Times Cited: 91
Possible involvement of Enterococcus infection in the pathogenesis of chronic pancreatitis and cancer
Tomohiro Maekawa, Risako Fukaya, Shinji Takamatsu, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 506, Iss. 4, pp. 962-969
Closed Access | Times Cited: 91
Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models
Marcel Alexander Heinrich, Ahmed M. R. H. Mostafa, Jennifer P. Morton, et al.
Advanced Drug Delivery Reviews (2021) Vol. 174, pp. 265-293
Open Access | Times Cited: 85
Modeling pancreatic cancer in mice for experimental therapeutics
Kavita Mallya, Shailendra K. Gautam, Abhijit Aithal, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188554-188554
Open Access | Times Cited: 58
Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies
Zeynep Nur Senturk, Isilay Akdag, Bahar Deniz, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top